retatrutide phase 2 results obesity nejm 2023 Weight loss with as compared to currently licenced Retatrutide Month 1 Results: Typical
Description
[8] Otvos Jr, L., & Wade, J
Weight suppression is a critical clinical risk factor

Maiorino, P

Is This Normal on GLP-1
- : GLP-1 GLP-1 , , -
